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Discovery phase proteomics has generated numerous candidate protein markers 
for a wide variety of biological processes and disease types. To assess the viability of 
these protein expression changes requires the analysis of a larger number of samples, 
preferably in a targeted fashion, and hence the use of MRM has become routine. 
Specific peptides from the proteins of interest are targeted as surrogate markers for that 
protein, in a screening assay using a triple quadrupole mass spectrometer operating in 
the multiple reaction monitoring (MRM) mode.  
The MRM method which is used to detect specific ions from target molecules 
has the capability to simultaneously quantify large numbers of proteins with good limits 
of quantification (LOQ) and linear dynamic range. In this mode of analysis the 
sensitivity and dynamic range are improved and providing sufficient data points across a 
chromatographic peak are recorded then quantitation is accurate (CV 5-10%). This high 
sensitivity coupled with the specificity/selectivity afforded by MRM transitions allows 
extensive panels of peptide biomarkers to be monitored in a single experiment from 
complex mixtures. 
We will describe the development and implementation of novel high-sensitivity 
MRM assays for large scale peptide quantification. 
 
